期刊文献+

充血性心力衰竭患者血浆脑钠肽水平与左室质量比值的相关性研究

Correlation between plasma level of brain natriuretic peptide and the ratio of observed/predicted left ventricular mass in patients with congestive heart failure
暂未订购
导出
摘要 目的探讨充血性心力衰竭(CHF)患者血浆脑钠肽(BNP)、肿瘤坏死因子(TNF-α)、内皮素(ET)的水平及与左室质量比值(PLM)的相关性.方法用放射免疫法测定71例CHF患者(CHF组,心功能Ⅱ~Ⅳ级)及30例体检正常者(对照组)血浆BNP、TNF-α、ET的水平;超声心动图测定CHF组及对照组左室质量,并根据收缩压计算左室质量预计值,PLM=左室质量实测值/左室质量预计值×100%.结果CHF组的血浆BNP、TNF-α、ET水平及PLM显著高于对照组(P<0.001),且BNP、TNF-α、ET水平与PL朋呈正相关,相关系数分别为r=0.79、P<0.01,r=0.60、P<0.05,r=0.56、P<0.05.结论CHF患者血浆BNP、TNF-α、ET水平明显增高,反映心室重构的PLM异常,BNP与PLM相关性最好. Objective To estimate the diagnostic value of plasma brain natriuretic peptide(BNP), tumor necrosis factor(TNF-α), endothelins(ET) in patients with congestive heart failure and the relationship with the ratio of observed/predicted left ventricular mass. Methods Plasma BNP,TNF-α,ET concentration of patients with CHF (CHF group,n=71) and those of normal controls (control group, n=30)were measured by radioimmunology assay. Left ventricular mass was measured by echocardiography. Result The plasma BNP,TNF-α,ET concentration of patients in CHF group were significantly higher than those in control group(P<0.001),they also increased according to the severity of heart failure classified by NYHA. The plasma BNP,TNF-α,ET level in CHF group had a positive correlation with % PLM respectively(r=0.79,P<0.01; r=0.60,P<0.05;r=0.56, P<0.05).Moreover, there was a significant positive correlation between the plasma level of BNP and % PLM. Conclusion The plasma BNP level was highly associated with the % PLM, it may be a useful biochemical parameter for evaluating the CHF. [
出处 《中国急救医学》 CAS CSCD 北大核心 2005年第4期251-253,共3页 Chinese Journal of Critical Care Medicine
关键词 心力衰竭 脑钠肽 左室质量比值 Congestive heart failure(CHF) Brain natriuretic peptide(BNP) The ratio of observed/predicted left ventricular mass(PLM)
  • 相关文献

参考文献8

  • 1张铖,叶平.炎性细胞因子与左心室重构[J].国外医学(老年医学分册),2004,25(1):29-32. 被引量:4
  • 2Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic,prognostic and therapeutic perspires[J] .Clin Physiol,2001,21 (6):661.
  • 3Palmieri V, de Simone G, Roman MJ, et al. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass[J]. Hypertension, 1999,34:1032- 1040.
  • 4谢春毅,劳晓翔,张家美,崔嬿.胶原纤维增生对慢性心力衰竭的影响及氯沙坦钾的干预作用[J].国外医学(心血管疾病分册),2003,30(5):310-312. 被引量:42
  • 5Palmieri V, Wachtell K, Gerdts E, et al. left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the life study[J] .Am Heart J,2O01,141:784 - 791.
  • 6de Simone G, Devereux RB, Roman MJ, et al. Inadequate, adequate and inappropriate left ventricular hypertrophy in arterial hypertension[ J ].Circulation, 1997,96(suppl Ⅰ ) : 1 - 89.
  • 7文丹,黄磊,姜德谦.左室质量比值和左室质量指数对高血压左室重构识别的比较[J].高血压杂志,2003,11(1):47-50. 被引量:8
  • 8Maisel A.B- Type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure:What's next[J]?Circulation,2002,105:2328-2334.

二级参考文献46

  • 1[1]Palmieri V, de Simone G, Roman MJ, et al. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass[J]. Hypertens, 1999, 34: 1032-1040.
  • 2[2]Mureddu GF, Pasanisi F, Palmieri V, et al. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy[J]. J Hypertens, 2001,19:1113-1119.
  • 3[3]Palmieri V, Wachtell K, Gerdts E, et al. Left ventricular function and hemodynamic features of inapporopriate left ventricular hypertrophy in patients with systemic hypertension: The LIFE Study[J]. Am Heart J, 2001,141:784-791.
  • 4[4]de Simone G, Palmieri V, Koren MJ, et al. Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension[J]. J Hypertens,2001,19:119-125.
  • 5[5]de Simone G, Devereux RB, Roman MJ, et al. Inadequate, adequate and inappropriate left ventricular hypertrophy in arterial hypertension[J]. Circulation, 1997,96(suppl I):I-89.
  • 6[6]Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparision to necropsy findings[J]. Am J Cardiol. 1986,57:450-458.
  • 7[7]Vakili BA, Okin PM, Devereux RB, Prognostic implications of left ventricular hypertrophy[J]. Am Heart J, 2001,141:334-341.
  • 8[8]Krumholz HM, Larsin M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study[J]. J Am Coll Cardiol, 1995,25:879-884.
  • 9[9]de Simone G, Devereux RB, Kimball TR, et al. Interaction between body size and cardiac workload influence on left ventricular mass during body growth and adulthood[J]. Hypertens,1998, 31: 1077-1082.
  • 10[10]Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension[J]. Ann Intern Med, 1991,114:345-352.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部